ID CONSULT

COVID-19 during pregnancy: How would you proceed in this case of a novel and ominous emerging pathogen?

Author and Disclosure Information

Your patient has just traveled from Italy. She has a fever, and she is 12 weeks’ gestation. What are the most likely diagnoses? What diagnostic tests and clinical treatments are indicated?


 

References

CASE Pregnant patient with fever who has travel history to Italy

A 28-year-old primigravid woman at 12 weeks’ gestation just returned from a 2-week vacation in Italy. She requests medical evaluation because of malaise; fever; chills; rhinorrhea; mild dyspnea; a dry, nonproductive cough; and diarrhea. On physical examination, her temperature is 38.6° C (101.5° F), pulse 104 bpm, respirations 22/minute, and blood pressure 100/70 mm Hg. Auscultation of the lungs demonstrates scattered rales, rhonchi, and expiratory wheezes in both posterior lung fields. The fetal heart rate is 168 bpm. What are the most likely diagnoses? What diagnostic tests are indicated? And what clinical treatment is indicated?

In the presented case scenario, the patient’s symptoms are consistent with a viral influenza. Her recent travel history certainly makes coronavirus disease 2019 (COVID-19) the most likely diagnosis.

COVID-19, caused by a novel new coronavirus, has evolved with lightning speed since it was first identified in early December 2019.1 The disease originated in Wuhan, China. Its epicenter is now in Europe, and over 100 countries and regions have reported cases. New cases in the United States are being identified daily, and there is no clear end to the outbreak. Several areas of the United States have been particularly hard hit by this disease: Seattle, New Orleans, and New York City.

COVID-19 has provoked widespread unsettledness in many populations and an extraordinary response from public health officials, large corporations, professional organizations, and financial markets. We are learning more about somewhat unfamiliar public health concepts such as quarantine, containment, mitigation, reproduction number (R), and “flattening the curve.” Disneyland and Walt Disney World are now temporarily closed. Professional and collegiate sports organizations have cancelled or suspended games and tournaments. Scientific and trade association meetings have been postponed or cancelled. Broadway, Carnegie Hall, and the Metropolitan Museum of Art have now “turned out the lights.” The Centers for Disease Control and Prevention has recommended that everyone avoid gatherings that include more than 10 other persons.

This article will review the evolving epidemiology of COVID-19, describe the usual clinical manifestations of the disease, highlight the key diagnostic tests, and present guidelines for treatment. It will review the limited information currently available about the impact of COVID-19 in pregnant women. The review will conclude by describing measures that individuals can employ to prevent acquisition or transmission of infection and then by highlighting key “unanswered questions” about this new and ominous pathogen (TABLE).

Continue to: What we know about epidemiology...

Pages

Recommended Reading

FDA provides flexibility to improve COVID-19 test availability
Covid ICYMI
COVID-19: Extra caution needed for patients with diabetes
Covid ICYMI
Treating COVID-19 in patients with diabetes
Covid ICYMI
Potential GI manifestation, transmission of coronavirus
Covid ICYMI
Coronavirus stays in aerosols for hours, on surfaces for days
Covid ICYMI
COVID-19 in pediatric patients: What the hospitalist needs to know
Covid ICYMI
White House expands Medicare telehealth services amid COVID-19
Covid ICYMI
During a viral pandemic, anxiety is endemic: The psychiatric aspects of COVID-19
Covid ICYMI
Physicians and health systems can reduce fear around COVID-19
Covid ICYMI
COVID-19 guidance for children’s health care providers
Covid ICYMI